Work

Cell-Penetrating TLR Inhibitor Peptide Ameliorates Experimental Autoimmune Encephalomyelitis and Promotes Efferocytosis in Microglia and Macrophages

Year: 2026
Type: article
Abstract: Toll-like receptor (TLR) signaling contributes to inflammatory activation during autoimmune neuroinflammation. We previously demonstrated that a cell-penetrating TLR inhibitory peptide (cpTLR-i), designed to interfere with TLR adaptor recruitment, alleviated experimental colitis through functional modulation of macrophages. Here, we investigated the therapeutic and immunomodulatory effects of cpTLR-i in experimental autoimmune encephalomyelitis (EAE). cpTLR-i suppressed inflammatory mediator production in activated BV2 microglia while preserving MHC class II expression. Systemic cpTLR-i treatment delayed EAE onset, reduced disease severity, and attenuated CNS inflammation and demyelination. Immune profiling revealed reduced granulocyte accumulation and type 1 CD4+ T cells, increased FoxP3+ regulatory T cells, and functional reprogramming of microglia and infiltrating macrophages. Notably, cpTLR-i enhanced apoptotic-cell uptake by microglia and macrophages in vitro and induced an efferocytosis-associated program characterized by increased LXRα and CD36 expression even in the absence of exogenous TLR ligands. Pharmacological inhibition further implicated LXR signaling in this response, while cpTLR-i altered SOCS/STAT3 signaling, revealing an unexpected association between modulation of TLR signaling and signaling networks involved in the regulation of efferocytosis. These findings demonstrate that cpTLR-i not only suppresses inflammatory responses but also promotes pro-resolving functions of microglia and macrophages, suggesting that selective modulation of TLR signaling represents a potential therapeutic strategy for neuroinflammatory diseases.
Institution: Hallym University
Language: English
Subfield: Neurology
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7225883245
FWCI:
Cites: 41
Cited by:
Related to: 10